| 0009-0082 | These highlights do not include all the information needed to use CAMPTOSAR safely and effectively. See full prescribing information for CAMPTOSAR. CAMPTOSAR ® (irinotecan hydrochloride) injection, for intravenous use Initial U.S. Approval: 1996 | Pharmacia & Upjohn Company LLC | Zydus Hospira Oncology Private Limited |
| 0009-0082-02 | These highlights do not include all the information needed to use CAMPTOSAR safely and effectively. See full prescribing information for CAMPTOSAR. CAMPTOSAR ® (irinotecan hydrochloride) injection, for intravenous use Initial U.S. Approval: 1996 | Pharmacia & Upjohn Company LLC | Zydus Hospira Oncology Private Limited |
| 0009-0112 | These highlights do not include all the information needed to use CAMPTOSAR safely and effectively. See full prescribing information for CAMPTOSAR. CAMPTOSAR ® (irinotecan hydrochloride) injection, for intravenous use Initial U.S. Approval: 1996 | Pharmacia & Upjohn Company LLC | Zydus Hospira Oncology Private Limited |
| 0009-0112-05 | These highlights do not include all the information needed to use CAMPTOSAR safely and effectively. See full prescribing information for CAMPTOSAR. CAMPTOSAR ® (irinotecan hydrochloride) injection, for intravenous use Initial U.S. Approval: 1996 | Pharmacia & Upjohn Company LLC | Zydus Hospira Oncology Private Limited |
| 0009-7529 | These highlights do not include all the information needed to use CAMPTOSAR safely and effectively. See full prescribing information for CAMPTOSAR. CAMPTOSAR ® (irinotecan hydrochloride) injection, for intravenous use Initial U.S. Approval: 1996 | Pharmacia & Upjohn Company LLC | Zydus Hospira Oncology Private Limited |
| 0009-7529-03 | These highlights do not include all the information needed to use CAMPTOSAR safely and effectively. See full prescribing information for CAMPTOSAR. CAMPTOSAR ® (irinotecan hydrochloride) injection, for intravenous use Initial U.S. Approval: 1996 | Pharmacia & Upjohn Company LLC | Zydus Hospira Oncology Private Limited |
| 0009-7529-04 | These highlights do not include all the information needed to use CAMPTOSAR safely and effectively. See full prescribing information for CAMPTOSAR. CAMPTOSAR ® (irinotecan hydrochloride) injection, for intravenous use Initial U.S. Approval: 1996 | Pharmacia & Upjohn Company LLC | Zydus Hospira Oncology Private Limited |
| 0009-7529-05 | These highlights do not include all the information needed to use CAMPTOSAR safely and effectively. See full prescribing information for CAMPTOSAR. CAMPTOSAR ® (irinotecan hydrochloride) injection, for intravenous use Initial U.S. Approval: 1996 | Pharmacia & Upjohn Company LLC | Zydus Hospira Oncology Private Limited |
| 0009-7529-10 | These highlights do not include all the information needed to use CAMPTOSAR safely and effectively. See full prescribing information for CAMPTOSAR. CAMPTOSAR ® (irinotecan hydrochloride) injection, for intravenous use Initial U.S. Approval: 1996 | Pharmacia & Upjohn Company LLC | Zydus Hospira Oncology Private Limited |
| 0143-9583 | These highlights do not include all the information needed to use irinotecan hydrochloride injection safely and effectively. See full prescribing information for Irinotecan Hydrochloride Injection, USP. Irinotecan Hydrochloride Injection, USP Initial U.S. Approval: 1996 | Hikma Pharmaceuticals USA Inc. | THYMOORGAN GMBH PHARMAZIE |
| 0143-9583-01 | These highlights do not include all the information needed to use irinotecan hydrochloride injection safely and effectively. See full prescribing information for Irinotecan Hydrochloride Injection, USP. Irinotecan Hydrochloride Injection, USP Initial U.S. Approval: 1996 | Hikma Pharmaceuticals USA Inc. | THYMOORGAN GMBH PHARMAZIE |
| 0143-9701 | These highlights do not include all the information needed to use irinotecan hydrochloride injection safely and effectively. See full prescribing information for Irinotecan Hydrochloride Injection, USP. Irinotecan Hydrochloride Injection, USP Initial U.S. Approval: 1996 | Hikma Pharmaceuticals USA Inc. | THYMOORGAN GMBH PHARMAZIE |
| 0143-9701-01 | These highlights do not include all the information needed to use irinotecan hydrochloride injection safely and effectively. See full prescribing information for Irinotecan Hydrochloride Injection, USP. Irinotecan Hydrochloride Injection, USP Initial U.S. Approval: 1996 | Hikma Pharmaceuticals USA Inc. | THYMOORGAN GMBH PHARMAZIE |
| 0143-9702 | These highlights do not include all the information needed to use irinotecan hydrochloride injection safely and effectively. See full prescribing information for Irinotecan Hydrochloride Injection, USP. Irinotecan Hydrochloride Injection, USP Initial U.S. Approval: 1996 | Hikma Pharmaceuticals USA Inc. | THYMOORGAN GMBH PHARMAZIE |
| 0143-9702-01 | These highlights do not include all the information needed to use irinotecan hydrochloride injection safely and effectively. See full prescribing information for Irinotecan Hydrochloride Injection, USP. Irinotecan Hydrochloride Injection, USP Initial U.S. Approval: 1996 | Hikma Pharmaceuticals USA Inc. | THYMOORGAN GMBH PHARMAZIE |
| 15054-0043 | These highlights do not include all the information needed to use ONIVYDE safely and effectively. See full prescribing information for ONIVYDE ONIVYDE® (irinotecan liposome injection), for intravenous use Initial U.S. Approval: 1996 | Ipsen Biopharmaceuticals, Inc. | ScinoPharm Taiwan Ltd. | Hubei Haosun Pharmaceuticals Co. Ltd | Ipsen Pharma Biotech | Boston Analytical | Quality Chemical Laboratories (QCL) | Avista |
| 15054-0043-1 | These highlights do not include all the information needed to use ONIVYDE safely and effectively. See full prescribing information for ONIVYDE ONIVYDE® (irinotecan liposome injection), for intravenous use Initial U.S. Approval: 1996 | Ipsen Biopharmaceuticals, Inc. | ScinoPharm Taiwan Ltd. | Hubei Haosun Pharmaceuticals Co. Ltd | Ipsen Pharma Biotech | Boston Analytical | Quality Chemical Laboratories (QCL) | Avista |
| 16714-027 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Northstar Rx LLC | Gland Pharma Limited |
| 16714-027-01 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Northstar Rx LLC | Gland Pharma Limited |
| 16714-131 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Northstar Rx LLC | Gland Pharma Limited |
| 16714-131-01 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Northstar Rx LLC | Gland Pharma Limited |
| 25021-230 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Sagent Pharmaceuticals | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) |
| 25021-230-02 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Sagent Pharmaceuticals | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) |
| 25021-230-05 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Sagent Pharmaceuticals | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) |
| 45963-614 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Actavis Pharma, Inc. |
| 45963-614-51 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Actavis Pharma, Inc. |
| 45963-614-55 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Actavis Pharma, Inc. |
| 50742-401 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Ingenus Pharmaceuticals, LLC |
| 50742-401 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Ingenus Pharmaceuticals, LLC | Novast Laboratories , Ltd. |
| 50742-401-02 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Ingenus Pharmaceuticals, LLC |
| 50742-401-02 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Ingenus Pharmaceuticals, LLC | Novast Laboratories , Ltd. |
| 50742-402 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Ingenus Pharmaceuticals, LLC |
| 50742-402 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Ingenus Pharmaceuticals, LLC | Novast Laboratories , Ltd. |
| 50742-402-05 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Ingenus Pharmaceuticals, LLC |
| 50742-402-05 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Ingenus Pharmaceuticals, LLC | Novast Laboratories , Ltd. |
| 55150-352 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Eugia US LLC | EUGIA Pharma Specialities Limited |
| 55150-352-01 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Eugia US LLC | EUGIA Pharma Specialities Limited |
| 55150-353 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Eugia US LLC | EUGIA Pharma Specialities Limited |
| 55150-353-01 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Eugia US LLC | EUGIA Pharma Specialities Limited |
| 55150-354 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Eugia US LLC | EUGIA Pharma Specialities Limited |
| 55150-354-01 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Eugia US LLC | EUGIA Pharma Specialities Limited |
| 55150-355 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Eugia US LLC | EUGIA Pharma Specialities Limited |
| 55150-355-01 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Eugia US LLC | EUGIA Pharma Specialities Limited |
| 59751-087 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, intravenous infusion Initial U.S. Approval: 1996 | Intas Pharmaceuticals | Intas Pharmaceuticals Limited |
| 59751-087-30 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, intravenous infusion Initial U.S. Approval: 1996 | Intas Pharmaceuticals | Intas Pharmaceuticals Limited |
| 59751-087-31 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, intravenous infusion Initial U.S. Approval: 1996 | Intas Pharmaceuticals | Intas Pharmaceuticals Limited |
| 59923-714 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Areva Pharmaceuticals, Inc. |
| 59923-714-02 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Areva Pharmaceuticals, Inc. |
| 59923-715 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Areva Pharmaceuticals, Inc. |
| 59923-715-05 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Areva Pharmaceuticals, Inc. |
| 59923-716 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Areva Pharmaceuticals, Inc. |
| 59923-716-15 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Areva Pharmaceuticals, Inc. |
| 60505-6128 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Apotex Corp. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 60505-6128-0 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Apotex Corp. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 60505-6128-1 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Apotex Corp. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 60505-6272 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Apotex Corp. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 60505-6272-1 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Apotex Corp. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 61703-349 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION, USP safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION, USP. IRINOTECAN HYDROCHLORIDE INJECTION, USP, for intravenous use Initial U.S. Approval: 1996 | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 61703-349-09 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION, USP safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION, USP. IRINOTECAN HYDROCHLORIDE INJECTION, USP, for intravenous use Initial U.S. Approval: 1996 | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 61703-349-16 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION, USP safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION, USP. IRINOTECAN HYDROCHLORIDE INJECTION, USP, for intravenous use Initial U.S. Approval: 1996 | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 61703-349-36 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION, USP safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION, USP. IRINOTECAN HYDROCHLORIDE INJECTION, USP, for intravenous use Initial U.S. Approval: 1996 | Hospira, Inc. | Zydus Hospira Oncology Private Limited |
| 63323-193 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 Rx only | Fresenius Kabi USA, LLC |
| 63323-193-52 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 Rx only | Fresenius Kabi USA, LLC |
| 63323-193-55 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 Rx only | Fresenius Kabi USA, LLC |
| 67184-0511 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 67184-0511-1 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 67184-0512 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 67184-0512-1 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 67184-0513 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 67184-0513-1 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. |
| 68001-480 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | BluePoint Laboratories | Gland Pharma Limited |
| 68001-480-22 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | BluePoint Laboratories | Gland Pharma Limited |
| 68001-480-35 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | BluePoint Laboratories | Gland Pharma Limited |
| 68083-381 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Gland Pharma Limited |
| 68083-381-01 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Gland Pharma Limited |
| 68083-382 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Gland Pharma Limited |
| 68083-382-01 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Gland Pharma Limited |
| 70700-169 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Xiromed LLC | Gland Pharma Limited |
| 70700-169-22 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Xiromed LLC | Gland Pharma Limited |
| 70700-170 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Xiromed LLC | Gland Pharma Limited |
| 70700-170-22 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996 | Xiromed LLC | Gland Pharma Limited |
| 72485-211 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous infusion Initial U.S. Approval: 1996 | Armas Pharmaceuticals Inc. |
| 72485-211-02 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous infusion Initial U.S. Approval: 1996 | Armas Pharmaceuticals Inc. |
| 72485-212 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous infusion Initial U.S. Approval: 1996 | Armas Pharmaceuticals Inc. |
| 72485-212-05 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous infusion Initial U.S. Approval: 1996 | Armas Pharmaceuticals Inc. |
| 72485-213 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous infusion Initial U.S. Approval: 1996 | Armas Pharmaceuticals Inc. |
| 72485-213-15 | These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous infusion Initial U.S. Approval: 1996 | Armas Pharmaceuticals Inc. |